Scientists have developed platelet-inspired nanoparticles that deliver anti-inflammatory drugs directly to brain-computer interface implants, doubling their effectiveness.
Scientists have found a way to improve the performance of brain-computer interface (BCI) electrodes by delivering anti-inflammatory drugs directly to the site of implantation. The study, led by researchers at Case Western Reserve University (CWRU) in collaboration with Haima Therapeutics, has the potential to treat a wide range of inflammatory diseases and improve devices that let people control prosthetic limbs with their thoughts.
Nanoparticles as a Trojan horse
The team used a novel ‘platelet-inspired nanoparticle’ to transport an anti-inflammatory drug directly to the brain where BCI electrodes are implanted, which doubled the effectiveness of the electrodes.
“When we implant devices in the brain, it disrupts the blood-brain barrier, and we knew platelets would be showing up to seal the breach,” said neural engineer Andrew Shoffstall, the Nord Distinguished Associate Professor of Biomedical Engineering in the Case School of Engineering and Case Western Reserve School of Medicine. “We used these nanoparticles that act like platelets as a Trojan horse to target the site where we’re putting the device.”
How brain-computer interfaces work
BCI technology allows people with spinal cord injuries or prosthetic limbs to operate devices or limbs by thinking about them. Electrodes implanted in the brain sense neuronal activity and translate it into commands. However, inflammation around the implants can interfere with signals, limiting the lifespan and effectiveness of the electrodes.
By delivering the drug directly using nanoparticles, the team improved electrode performance.
“The brain recognises the implant as a foreign object – like a splinter – and it responds with inflammation to try to isolate and neutralise it,” Shoffstall explained.
By delivering the drug directly using nanoparticles, the team improved electrode performance, whereas administering the same drug systemically actually worsened results. The team now plans to move the research towards translation, starting with safety studies.
Synthetic platelets enable precision delivery
The approach relies on synthetic platelet technology developed by Anirban Sen Gupta, Wallace R. Persons professor of biomedical engineering, who patented it and licensed it to Haima Therapeutics, a biotech start-up he co-founded with CWRU alumna and COO Christa Pawlowski.
The technology, known as SynthoPlate, could have wider applications, including controlling life-threatening bleeding and targeted drug delivery.
Future clinical applications for different diseases
“Because the particle itself is a platform, you can load it with any drug, as long as you pick a disease or pathology where platelets can accumulate,” Sen Gupta said. “Really, it has potential for treating any disease that involves vascular injury and inflammation, from stroke and heart attack to autoimmune disorders like rheumatoid arthritis or infectious diseases like sepsis.”
Because the particle itself is a platform, you can load it with any drug.
Haima Therapeutics plans to begin human clinical trials of the platelet-inspired nanoparticles in 2027 and recently secured two Small Business Innovation Research Grants from the Defense Advanced Research Projects Agency (DARPA) to advance the technology towards clinical translation.
News
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
